These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32874063)

  • 21. Higher IL-6 peri-tumoural expression is associated with gastro-intestinal neuroendocrine tumour progression.
    Pereira SS; Pereira R; Santos AP; Costa MM; Morais T; Sampaio P; Machado B; Afonso LP; Henrique R; Monteiro MP
    Pathology; 2019 Oct; 51(6):593-599. PubMed ID: 31466863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
    Herrera-Martínez AD; Gahete MD; Pedraza-Arevalo S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Luque RM; Gálvez-Moreno MA; Castaño JP
    Endocrine; 2018 Feb; 59(2):426-437. PubMed ID: 29196939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Small bowel neuroendocrine tumours: to be considered in the differential diagnosis of unexplained abdominal pain and diarrhoea].
    Franssen GJH; van Ginhoven TM; Hofland J; Feelders RA; Geilvoet W; van Lanschot JB
    Ned Tijdschr Geneeskd; 2020 Jan; 164():. PubMed ID: 32186828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine Tumors and Lanreotide Depot: Clinical Considerations and Nurse and Patient Preferences.
    Ryan P; Phan AT; Adelman DT; Iwasaki M
    Clin J Oncol Nurs; 2016 Dec; 20(6):E139-E146. PubMed ID: 27857269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
    Yang XO; Li JN; Qian JM; Yang H; Chen Q; Lu L
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):124-7. PubMed ID: 21418832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.
    Jin XF; Spampatti MP; Spitzweg C; Auernhammer CJ
    Rev Endocr Metab Disord; 2018 Jun; 19(2):145-158. PubMed ID: 29464446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors.
    Naraev BG; Mailman J; Halfdanarson TR; Soares HP; Mittra ES; Hallet J
    Expert Rev Anticancer Ther; 2023 Jun; 23(6):601-615. PubMed ID: 37158050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study.
    Lamarca A; McCallum L; Nuttall C; Barriuso J; Backen A; Frizziero M; Leon R; Mansoor W; McNamara MG; Hubner RA; Valle JW
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):723-731. PubMed ID: 29923433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
    Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
    Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA
    Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.
    Guo LJ; Wang CH; Tang CW
    Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The state of the art of imaging in gastroenteropancreatic neuroendocrine tumors].
    Yao X; Wang F
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 45(1):51-5. PubMed ID: 27045241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.
    Tomassetti P; Migliori M; Lalli S; Campana D; Tomassetti V; Corinaldesi R
    Ann Oncol; 2001; 12 Suppl 2():S95-9. PubMed ID: 11762360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETS): current approaches and future options.
    Strosberg JR
    Endocr Pract; 2014 Feb; 20(2):167-75. PubMed ID: 24014009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
    Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
    Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Phan AT; Kunz PL; Reidy-Lagunes DL
    Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours.
    Srirajaskanthan R; Toumpanakis C; Meyer T; Caplin ME
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1143-54. PubMed ID: 19298583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.
    Deppen SA; Blume J; Bobbey AJ; Shah C; Graham MM; Lee P; Delbeke D; Walker RC
    J Nucl Med; 2016 Jun; 57(6):872-8. PubMed ID: 26769864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.
    Eads JR; Reidy-Lagunes D; Soares HP; Chan JA; Anthony LB; Halfdanarson TR; Naraev BG; Wolin EM; Halperin DM; Li D; Pommier RF; Zacks JS; Morse MA; Metz DC;
    Pancreas; 2020 Oct; 49(9):1123-1130. PubMed ID: 32991344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.